EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62 | -69.6% | 18,195 | -34.3% | 0.00% | – |
Q2 2023 | $204 | -16.7% | 27,690 | +17.2% | 0.00% | – |
Q1 2023 | $245 | -8.6% | 23,631 | +4.0% | 0.00% | – |
Q4 2022 | $268 | -100.0% | 22,717 | -19.3% | 0.00% | – |
Q3 2022 | $592,000 | -85.7% | 28,139 | -78.8% | 0.00% | -100.0% |
Q2 2022 | $4,126,000 | -60.1% | 132,927 | -47.2% | 0.00% | 0.0% |
Q1 2022 | $10,334,000 | -12.6% | 251,689 | -7.5% | 0.00% | 0.0% |
Q4 2021 | $11,827,000 | -56.3% | 272,073 | -49.7% | 0.00% | -66.7% |
Q3 2021 | $27,065,000 | -22.4% | 540,549 | -2.4% | 0.00% | 0.0% |
Q2 2021 | $34,899,000 | -51.5% | 554,036 | -28.5% | 0.00% | -57.1% |
Q1 2021 | $72,010,000 | -7.9% | 775,054 | -11.2% | 0.01% | -12.5% |
Q4 2020 | $78,164,000 | -14.6% | 872,367 | -1.5% | 0.01% | -27.3% |
Q3 2020 | $91,527,000 | +32.4% | 885,771 | +1.3% | 0.01% | +22.2% |
Q2 2020 | $69,148,000 | +35.3% | 874,402 | -1.0% | 0.01% | +12.5% |
Q1 2020 | $51,123,000 | +6.6% | 883,570 | -0.6% | 0.01% | +33.3% |
Q4 2019 | $47,980,000 | +5.4% | 889,339 | +2.2% | 0.01% | 0.0% |
Q3 2019 | $45,511,000 | +15.8% | 870,528 | +7.0% | 0.01% | 0.0% |
Q2 2019 | $39,287,000 | -4.7% | 813,233 | -0.3% | 0.01% | 0.0% |
Q1 2019 | $41,207,000 | -9.2% | 815,657 | +6.6% | 0.01% | -25.0% |
Q4 2018 | $45,364,000 | -5.7% | 765,254 | +4.7% | 0.01% | +14.3% |
Q3 2018 | $48,106,000 | +55.6% | 730,762 | +19.3% | 0.01% | +40.0% |
Q2 2018 | $30,925,000 | +76.2% | 612,489 | +83.8% | 0.01% | +66.7% |
Q1 2018 | $17,547,000 | +2562.7% | 333,282 | +2248.7% | 0.00% | – |
Q4 2017 | $659,000 | +14.8% | 14,190 | -0.1% | 0.00% | – |
Q3 2017 | $574,000 | +19.1% | 14,200 | 0.0% | 0.00% | – |
Q2 2017 | $482,000 | +17.0% | 14,200 | +0.1% | 0.00% | – |
Q1 2017 | $412,000 | -11.6% | 14,190 | +0.1% | 0.00% | – |
Q4 2016 | $466,000 | +47.9% | 14,180 | +42.1% | 0.00% | – |
Q3 2016 | $315,000 | +21.2% | 9,980 | -27.0% | 0.00% | – |
Q3 2013 | $260,000 | – | 13,673 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 152,699 | $519,178 | 0.34% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 299,187 | $1,017,000 | 0.22% |
Hilltop Holdings Inc. | 235,019 | $799,064 | 0.09% |
AIMZ Investment Advisors, LLC | 51,372 | $174,665 | 0.08% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 868,605 | $2,953,257 | 0.07% |
PALISADE CAPITAL MANAGEMENT, LP | 509,325 | $1,731,705 | 0.05% |
SHERBROOKE PARK ADVISERS LLC | 41,417 | $140,818 | 0.04% |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2,428,490 | $8,256,866 | 0.03% |
Y-Intercept (Hong Kong) Ltd | 75,362 | $256,231 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,246,020 | $4,236,468 | 0.02% |